Corporate

CLINUVEL
Posted by CLINUVEL
September 19, 2023

CEO letter to shareholders

Melbourne, Australia, 19 September 2023 ASX: CUV Frankfurt Börse: UR9 Level 1...

Read More
CLINUVEL
Posted by CLINUVEL
August 30, 2023

Investor Webinar transcript

Melbourne, Australia, 30 August 2023 ASX: CUV Frankfurt Börse: UR9 Level 1...

Read More
CLINUVEL
Posted by CLINUVEL
August 29, 2023

CLINUVEL delivering on a long-term strategy with increase in annual revenues, profit

Melbourne, Australia, 29 August 2023 ASX: CUV XETRA-DAX: UR9 Level 1 ADR:...

Read More
CLINUVEL
Posted by CLINUVEL
August 23, 2023

Annual Results – Investor Webinar

Melbourne, Australia, 28 August 2023 ASX: CUV XETRA-DAX: UR9 Level 1 ADR:...

Read More
CLINUVEL
Posted by CLINUVEL
August 15, 2023

Afamelanotide Significantly Reduces DNA Damage in a Healthy Population

CLINUVEL has been awarded a five-year contract by the U.S. Department of...

Read More
CLINUVEL
Posted by CLINUVEL
July 26, 2023

SCENESSE® applied under five-year Veterans Affairs contract

CLINUVEL has been awarded a five-year contract by the U.S. Department of...

Read More
CLINUVEL
Posted by CLINUVEL
July 14, 2023

CLINUVEL secures IP for melanocortins to treat central nervous system disorders

CLINUVEL has secured a family of patents and patent applications relating to...

Read More
CLINUVEL
Posted by CLINUVEL
June 30, 2023

News Kommuniqué III

Melbourne, Australia, 26 June 2023 ASX: CUV XETRA-DAX: UR9 Level 1 ADR:...

Read More
CLINUVEL
Posted by CLINUVEL
June 29, 2023

Twilight Event - Briefing

CLINUVEL presented during a Twilight Briefing, after the close of market yesterday....

Read More
CLINUVEL
Posted by CLINUVEL
June 26, 2023

News Communiqué III

CLINUVEL’s News Communiqué III reviews the Company’s trajectory, and underlying reasons to...

Read More
CLINUVEL
Posted by CLINUVEL
June 1, 2023

Strategic Update VI

CLINUVEL today announced its sixth Strategic Update.

Read More
CLINUVEL
Posted by CLINUVEL
April 11, 2023

News Kommuniqué II

Melbourne, Australia, 12 January 2023 ASX: CUV XETRA-DAX: UR9 Level 1 ADR:...

Read More
CLINUVEL
Posted by CLINUVEL
April 5, 2023

News Communiqué II

Download the PDF Authorised for ASX release by the Board of Directors...

Read More
CLINUVEL
Posted by CLINUVEL
March 10, 2023

News Communiqué I - Maestro Jaap van Zweden

Introducing CLINUVEL Intriguing Personality (CUVIP), Maestro Jaap van Zweden.

Read More
CLINUVEL
Posted by CLINUVEL
March 1, 2023

CLINUVEL launches CYACÊLLE, Next Generation Solar Care

Melbourne, Australia, 01 March 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More